Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY13.98 CNY
Change Today 0.00 / 0.00%
Volume 0.0
300181 On Other Exchanges
As of 3:05 AM 02/5/15 All times are local (Market data is delayed by at least 15 minutes).

zhejiang jolly pharmaceuti-a (300181) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/10/14 - CNY16.99
52 Week Low
04/29/14 - CNY10.26
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ZHEJIANG JOLLY PHARMACEUTI-A (300181)

Related News

No related news articles were found.

zhejiang jolly pharmaceuti-a (300181) Related Businessweek News

No Related Businessweek News Found

zhejiang jolly pharmaceuti-a (300181) Details

Zhejiang Jolly Pharmaceutical Co., Ltd. is engaged in the research, production, and sale of pharmaceutical products. It primarily offers Wuling capsule that improves central nervous system, enhances stamina and endurance, and supports the immune system; and Wuling powder for improving central nervous system. The company also provides other products, such as Ling Lotus particles, Ginkgo biloba, clindamycin phosphate injection, etc. Zhejiang Jolly Pharmaceutical Co., Ltd. was founded in 2000 is based in Deqing, China.

Founded in 2000

zhejiang jolly pharmaceuti-a (300181) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang jolly pharmaceuti-a (300181) Key Developments

Zhejiang Jolly Pharmaceutical Co., Ltd. Proposes Cash Dividend for 2014

Zhejiang Jolly Pharmaceutical Co., Ltd. proposed cash dividend of CNY 2.00000000 per 10 shares (tax included) for 2014 to be approved by shareholders at the AGM to be held on April 28, 2015.

Zhejiang Jolly Pharmaceutical Co., Ltd. to Report Fiscal Year 2014 Results on Mar 27, 2015

Zhejiang Jolly Pharmaceutical Co., Ltd. announced that they will report fiscal year 2014 results on Mar 27, 2015

Zhejiang Jolly Pharmaceutical Co., Ltd. Approves Amendments to Articles of Association

Zhejiang Jolly Pharmaceutical Co., Ltd. approved amendments to the company's articles of association at its EGM held on October 9, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300181:CH CNY13.98 CNY 0.00

300181 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300181.
View Industry Companies

Industry Analysis


Industry Average

Valuation 300181 Industry Range
Price/Earnings 43.6x
Price/Sales 9.1x
Price/Book 5.7x
Price/Cash Flow 43.0x
TEV/Sales 7.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG JOLLY PHARMACEUTI-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at